Xia, P., Cao, J., Lv, X., Wang, L., Lv, W., & Hu, J. (2018). Combination therapy of apatinib with icotinib for primary acquired icotinib resistance in patients with advanced pulmonary adenocarcinoma with EGFR mutation. Thorac Cancer.
シカゴスタイル引用形Xia, Pinghui, Jinlin Cao, Xiayi Lv, Luming Wang, Wang Lv, , Jian Hu. "Combination Therapy of Apatinib With Icotinib for Primary Acquired Icotinib Resistance in Patients With Advanced Pulmonary Adenocarcinoma With EGFR Mutation." Thorac Cancer 2018.
MLA引用形式Xia, Pinghui, et al. "Combination Therapy of Apatinib With Icotinib for Primary Acquired Icotinib Resistance in Patients With Advanced Pulmonary Adenocarcinoma With EGFR Mutation." Thorac Cancer 2018.
警告: この引用は必ずしも正確ではありません.